D. Paillotin
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Genetics top 10%
- Epidemiology
- Molecular Biology
- Topics
- Lung Cancer Treatments and Mutations (17 papers)Lung Cancer Research Studies (12 papers)Cancer therapeutics and mechanisms (5 papers)
- Partner nations
- FranceCameroonLuxembourg
In The Last Decade
D. Paillotin
23 papers receiving 575 citations
Peers
Comparison fields: 5 of 43
- Pulmonary and Respiratory Medicine 498
- Oncology 486
- Genetics 104
- Epidemiology 89
- Molecular Biology 63
Countries citing papers authored by D. Paillotin
This map shows the geographic impact of D. Paillotin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Paillotin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Paillotin more than expected).
Fields of papers citing papers by D. Paillotin
This network shows the impact of papers produced by D. Paillotin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Paillotin. The network helps show where D. Paillotin may publish in the future.
Co-authorship network of co-authors of D. Paillotin
This figure shows the co-authorship network connecting the top 25 collaborators of D. Paillotin. A scholar is included among the top collaborators of D. Paillotin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Paillotin. D. Paillotin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 181 | |
| 2 | 27 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 12 | |
| 11 | 198 | |
| 12 | 31 | |
| 13 | [Phase II study of docetaxel in inoperable advanced non small cell lung cancer]. | 9 |
| 14 | [Efficacy of docetaxel in non-small cell lung cancer patients previously treated with platinum-containing chemotherapy. French Group of Pneumo-Cancerology]. | 8 |
| 15 | [High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)]. | 4 |
| 16 | 13 | |
| 17 | 2 | |
| 18 | 21 | |
| 19 | Dose optimization of gallium chloride, orally administered, in combination with platinum compounds. | 1 |
| 20 | [Mediastinal bronchogenic cyst associated with a multiple malformation syndrome]. | 1 |
About D. Paillotin
D. Paillotin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 24 papers that have together received 591 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (12 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (486 citations), Pulmonary and Respiratory Medicine (498 citations) and Genetics (104 citations). D. Paillotin has collaborated with scholars based in France, Cameroon and Luxembourg. Frequent co-authors include G. Robinet, H. Léna, H. Bérard, P. Thomas, I. Monnet, R. Gervais, M. Pérol, Fabrice Barlési, Abdesslam Chajara and J. Hureaux. Their work appears in journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.